Relay Therapeutics Inc is trading 4.3% up today at $14.07 as the stock bounces back from recent weakness tied to its discounted equity offering.
- Investors are reassessing last week’s sharp pullback driven by dilution concerns from a roughly $275 million stock sale.
- The recovery comes as biotech and tech risk appetite stabilizes alongside firmer performance in major U.S. indices.
- No fresh company-specific announcements were reported this morning, suggesting a technical rebound after the recent selloff.